Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manuel J Rial

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Frontiers in Allergy|June 30, 2022
Inflammatory Remission in T2 Severe AsthmaManuel J Rial, Javier Domínguez-Ortega
Current Opinion in Pulmonary Medicine|November 6, 2019
Long and winding road: from infant wheeze to adult asthmaSilvia Sánchez-García, Manuel J Rial, Javier Domínguez-Ortega
Frontiers in Allergy|February 19, 2024
Editorial: A multidisciplinary approach to treatment of severe chronic airway disease (CAD): focus on biomarkersRaquel López-Rodríguez, Irina Bobolea, Carlos Melero, et al.
Journal of Asthma and Allergy|February 19, 2026
Green Light for Response: Clinical Stratification of Response to Biologic Therapy in Severe AsthmaRaquel Lopez-Rodríguez, José Antonio Cañas, Ignacio Mahíllo-Fernández, et al.
Allergologia Et Immunopathologia|November 8, 2024
Four-month real-life response to Tezepelumab in patients with multi-failure to other biologicsDiana Betancor, Sara Bautista, Raquel López-Rodríguez, et al.
Journal of Asthma and Allergy|November 11, 2025
Evolution of Disease Burden in Severe Asthma Patients by Biological Treatment Status: Interim Analysis of the BREATHE StudyIñigo Ojanguren, Francisco Ramos-Lima, Gabriel Niza, et al.
Journal of Investigational Allergology & Clinical Immunology|March 5, 2026
Purinergic Receptors as Emerging Targets in the Management of Chronic Cough: From Pathophysiology to Clinical ApplicationManuel J Rial, Paula Galván, Darío Antolín Amérigo, et al.
International Journal of Molecular Sciences|April 3, 2021
Changes in Serum MicroRNAs after Anti-IL-5 Biological Treatment of Severe AsthmaManuel J Rial, José A Cañas, José M Rodrigo-Muñoz, et al.
Immunity, Inflammation and Disease|April 28, 2022
Effectiveness and safety of a microcrystalline tyrosine-adjuvanted Dermatophagoides pteronyssinus allergoid immunotherapy in adult patients with allergic asthma and rhinitis: A real-life prospective observational studyClara Padró, Diego Gutiérrez, Francisco Moreno, et al.
The World Allergy Organization Journal|June 28, 2021
Immunological parameters as biomarkers of response to MicroCrystalline Tyrosine-adjuvanted mite immunotherapyJosé L Justicia, Clara Padró, Albert Roger, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Frontiers in Allergy|June 30, 2022
Inflammatory Remission in T2 Severe AsthmaManuel J Rial, Javier Domínguez-Ortega
Current Opinion in Pulmonary Medicine|November 6, 2019
Long and winding road: from infant wheeze to adult asthmaSilvia Sánchez-García, Manuel J Rial, Javier Domínguez-Ortega
Frontiers in Allergy|February 19, 2024
Editorial: A multidisciplinary approach to treatment of severe chronic airway disease (CAD): focus on biomarkersRaquel López-Rodríguez, Irina Bobolea, Carlos Melero, et al.
Journal of Asthma and Allergy|February 19, 2026
Green Light for Response: Clinical Stratification of Response to Biologic Therapy in Severe AsthmaRaquel Lopez-Rodríguez, José Antonio Cañas, Ignacio Mahíllo-Fernández, et al.
Allergologia Et Immunopathologia|November 8, 2024
Four-month real-life response to Tezepelumab in patients with multi-failure to other biologicsDiana Betancor, Sara Bautista, Raquel López-Rodríguez, et al.
Journal of Asthma and Allergy|November 11, 2025
Evolution of Disease Burden in Severe Asthma Patients by Biological Treatment Status: Interim Analysis of the BREATHE StudyIñigo Ojanguren, Francisco Ramos-Lima, Gabriel Niza, et al.
Journal of Investigational Allergology & Clinical Immunology|March 5, 2026
Purinergic Receptors as Emerging Targets in the Management of Chronic Cough: From Pathophysiology to Clinical ApplicationManuel J Rial, Paula Galván, Darío Antolín Amérigo, et al.
International Journal of Molecular Sciences|April 3, 2021
Changes in Serum MicroRNAs after Anti-IL-5 Biological Treatment of Severe AsthmaManuel J Rial, José A Cañas, José M Rodrigo-Muñoz, et al.
Immunity, Inflammation and Disease|April 28, 2022
Effectiveness and safety of a microcrystalline tyrosine-adjuvanted Dermatophagoides pteronyssinus allergoid immunotherapy in adult patients with allergic asthma and rhinitis: A real-life prospective observational studyClara Padró, Diego Gutiérrez, Francisco Moreno, et al.
The World Allergy Organization Journal|June 28, 2021
Immunological parameters as biomarkers of response to MicroCrystalline Tyrosine-adjuvanted mite immunotherapyJosé L Justicia, Clara Padró, Albert Roger, et al.
Pageof 2